{"filing":{"accession_number":"0001819790-26-000048","cik":"0001819790","ticker":"TARS","company_name":"Tarsus Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-07-13","report_date":null,"primary_document":"tars-20260713.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979026000048/tars-20260713.htm"},"events":[{"id":17596,"run_id":15763,"accession_number":"0001819790-26-000048","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Aziz Mottiwala, the Chief Commercial Officer, is departing his employment with Tarsus Pharmaceuticals effective July 15, 2026, to pursue a CEO role elsewhere. The disclosure centers on the departure of a named executive officer from the Company, making this an exec_departure event. The loss of a CCO is material to investors assessing the registrant's commercial leadership and execution capability.","company_name":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","filing_date":"2026-07-13","form":"8-K","submitted_at":null,"items":[{"id":16133,"accession_number":"0001819790-26-000048","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Aziz Mottiwala, the Chief Commercial Officer, is departing his employment with Tarsus Pharmaceuticals effective July 15, 2026, to pursue a CEO role elsewhere. The disclosure centers on the departure of a named executive officer from the Company, making this an exec_departure event. The loss of a CCO is material to investors assessing the registrant's commercial leadership and execution capability.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:13:36.158581+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16133,"accession_number":"0001819790-26-000048","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Aziz Mottiwala, the Chief Commercial Officer, is departing his employment with Tarsus Pharmaceuticals effective July 15, 2026, to pursue a CEO role elsewhere. The disclosure centers on the departure of a named executive officer from the Company, making this an exec_departure event. The loss of a CCO is material to investors assessing the registrant's commercial leadership and execution capability.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:13:36.158581+00:00","company_name":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","filing_date":"2026-07-13"}]}